Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

People with knowledge of the matter said that General Motors Co., which is the largest auto manufacturer in the U.S., is trying to restore and improve the efficiency of its legal department while it its trying to eliminate the reasons that led to a delay of the vehicle recalls.

Moreover, General Motors Co. added another 2.4 million vehicles to the list of recent safety withdrawals, which raised its repair costs to 1.7 billion dollars. 29 separate recalls have been revealed by the company since the beginning of 2014. The withdrawals amount to a total of 15.4 million vehicles globally, which equals to about 150% of the companys production generated in 2013.

General Motors Co. made a statement, saying that the latest recalls would cost about 200 million dollars as the Chief Executive Officer of the company Mrs. Mary Barra is trying to improve its quality processes in an attempt to prove GMs vehicles are safe enough.

According to the companys official announcement, there were various vehicle models included in the latest withdrawals. As reported by the Financial Times, General Motors reported that there werent any fatalities related to the faults, and explained that the recalls were part of “a continuing effort to quickly address emerging safety issues”.

One of the people familiar with the process reported that Mr. Michael Millikin, who is the General Counsel of the company, took the initiative of assigning a legal adviser to work in cooperation of global safety and vehicle development units managers to make the information flow faster. Currently the company is doing everything possible in order to repair its corrupted safety reputation.

Mr. Millikin revealed there may be further changes after the completion of the internal investigation carried out by the company. The process is expected to be finalized in the next few weeks, according to a person close to the issues, who asked not to be identified because the investigations are not public.

General Motors Co. was 3.45% down to close at 33.07 dollars per share yesterday, marking a one-year change of -1.87%. According to the information published on CNN Money, the 17 analysts offering 12-month price forecasts for General Motors Co. have a median target of 44.00, with a high estimate of 50.00 and a low estimate of 32.00. The median estimate represents a +33.05% increase from the last price of 33.07.

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • Silver Bounce Falters Below Key Technical BarriersSilver Bounce Falters Below Key Technical Barriers Key Moments XAG/USD trades near $60.50, recovering from an intraday drop to the mid-$59.00s with gains just above 0.30%. The US Dollar pulls back from an 18-month high, lending support to silver prices despite the Federal […]
  • Vodafone slashes full-year cash flow, earnings forecastsVodafone slashes full-year cash flow, earnings forecasts Vodafone on Tuesday revised down its full-year cash flow and adjusted core earnings forecasts amid surging energy costs and a deteriorating performance in markets such as Germany, Italy and Spain.Due to a "challenging macroeconomic […]
  • Gold slips back to negative territory on upbeat U.S. dataGold slips back to negative territory on upbeat U.S. data Gold fell back to negative territory in the early U.S. session after trading mostly higher throughout the day as upbeat U.S. jobless data hinted that tomorrows non-farm payrolls and unemployment rate will probably post positive readings as […]
  • USD/KRW: Won gains as Bank of Korea hints at policy pivotUSD/KRW: Won gains as Bank of Korea hints at policy pivot The South Korean Won firmed against the US Dollar on Thursday, after the Bank of Korea (BOK) hinted it might pivot towards monetary easing amid a further slowdown in inflation and record household debt levels.The central bank left its […]
  • Onyx attracting Pfizer, Novartis in a buyout raceOnyx attracting Pfizer, Novartis in a buyout race Onyx Pharmaceuticals, Inc. is a bio-pharmaceutical company. The Company is developing therapies that target the molecular mechanisms which cause cancer. The company has a promising investing future and according to Reuters has added two large […]
  • Pfizer Inc share price up, posts steady Q2 revenue and profit, lowers outlookPfizer Inc share price up, posts steady Q2 revenue and profit, lowers outlook Pfizer Inc, the leading US drugmaker, posted quarterly earnings today, revealing steady revenue and profit, with declining sales for major divisions and climbing R&D expenses. Full-year outlook was slightly lowered, but still relatively […]